Experienced in Mosaicism

Dr. Amy S. Paller

Pediatrics
Northwestern Medical Group
676 N St Clair St Ste 1600, Arkes Pavilion, 
Chicago, IL 
Clinical Trials:Currently Recruiting for 2 Trials
48 Years of Experience

Experienced in Mosaicism
Northwestern Medical Group
676 N St Clair St Ste 1600, Arkes Pavilion, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Amy Paller is a Pediatrics provider in Chicago, Illinois. Dr. Paller has been practicing medicine for over 48 years and is rated as an Experienced provider by MediFind in the treatment of Mosaicism. Her top areas of expertise are Ectodermal Dysplasias, Clouston Syndrome, Plaque Psoriasis, Discoid Lupus Erythematosus (DLE), and Gastrostomy.

Her clinical research consists of co-authoring 477 peer reviewed articles and participating in 21 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles in the study of Mosaicism.

Graduate Institution
Stanford University School Of Medicine, 1978.0
Residency
McGaw Medical Center of Northwestern University
Specialties
Pediatrics
Licenses
Pediatrics in IL
Board Certifications
American Board Of Dermatology - Dermatology (Certified)
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

676 N St Clair St Ste 1600, Arkes Pavilion, Chicago, IL 60611
Call: 312-695-3721

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


21 Clinical Trials

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Enrollment Status: Recruiting
Publish Date: October 14, 2025
Systems Biology of Early Atopy
Systems Biology of Early Atopy
Enrollment Status: Recruiting
Publish Date: May 16, 2025
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment
Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment
Enrollment Status: Completed
Publish Date: July 29, 2025
Intervention Type: Other
Determining Effects of Superfine Sheep Wool in INfantile Eczema (DESSINE 2): a Multicentre Randomized Crossover Study
Determining Effects of Superfine Sheep Wool in INfantile Eczema (DESSINE 2): a Multicentre Randomized Crossover Study
Enrollment Status: Completed
Publish Date: May 25, 2025
Intervention Type: Other
Study Phase: Not Applicable
Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis SUB-STUDY: Defining the Predictive Non-Invasive Biomarkers for Pediatric Atopic Dermatitis (Funded by Regeneron Pharmaceuticals, Inc.)
Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis SUB-STUDY: Defining the Predictive Non-Invasive Biomarkers for Pediatric Atopic Dermatitis (Funded by Regeneron Pharmaceuticals, Inc.)
Enrollment Status: Active_not_recruiting
Publish Date: April 27, 2025
Defining the Skin and Blood Biomarkers of Ichthyosis
Defining the Skin and Blood Biomarkers of Ichthyosis
Enrollment Status: Enrolling_by_invitation
Publish Date: April 24, 2025
An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With Ichthyoses.
An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With Ichthyoses.
Enrollment Status: Completed
Publish Date: February 12, 2025
Intervention Type: Drug
Study Drug: Ustekinumab
Study Phase: Early Phase 1
Open Label Treatment of Beremagene Geperpavec (B-VEC)
Open Label Treatment of Beremagene Geperpavec (B-VEC)
Enrollment Status: Completed
Publish Date: April 09, 2024
Intervention Type: Biological
Study Drug: Open Label Topical Beremagene Geperpavec (B-VEC)
Study Phase: Phase 3
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 24, 2023
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Phase III Efficacy and Safety Study of Beremagene Geperpavec (B-VEC, Previously KB103) for the Treatment of Dystrophic Epidermolysis Bullosa (DEB)
A Phase III Efficacy and Safety Study of Beremagene Geperpavec (B-VEC, Previously KB103) for the Treatment of Dystrophic Epidermolysis Bullosa (DEB)
Enrollment Status: Completed
Publish Date: February 17, 2023
Intervention Type: Biological, Other
Study Drug: Topical Beremagene Geperpavec
Study Phase: Phase 3
A Randomized,Single-Blind, Placebo-controlled, Self-matched Pairing, Independent Evaluated Study to Evaluate the Efficacy and Safety of RGN-137 Topical Gel in Subjects With Junctional and Dystrophic Epidermolysis Bullosa (CELEB)
A Randomized,Single-Blind, Placebo-controlled, Self-matched Pairing, Independent Evaluated Study to Evaluate the Efficacy and Safety of RGN-137 Topical Gel in Subjects With Junctional and Dystrophic Epidermolysis Bullosa (CELEB)
Enrollment Status: Terminated
Publish Date: August 22, 2022
Intervention Type: Drug
Study Drug: RGN-137
Study Phase: Phase 2
A Smart, Always -On Health Monitoring System, Sub-Study: No Strings Attached: Wireless Sensor Technology in the Prentice NICU
A Smart, Always -On Health Monitoring System, Sub-Study: No Strings Attached: Wireless Sensor Technology in the Prentice NICU
Enrollment Status: Completed
Publish Date: June 14, 2022
Intervention Type: Device
Genetic Analysis of Pediatric Psoriasis
Genetic Analysis of Pediatric Psoriasis
Enrollment Status: Completed
Publish Date: April 20, 2022
Intervention Type: Other
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 Years and Older) With Molluscum Contagiosum
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 Years and Older) With Molluscum Contagiosum
Enrollment Status: Completed
Publish Date: December 14, 2021
Intervention Type: Combination product
Study Phase: Phase 3
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: September 27, 2021
Intervention Type: Drug
Study Phase: Phase 3
An Open-Label, Pilot Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
An Open-Label, Pilot Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 1
AAD-PEPR: Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments Sub-Study: Clinically Relevant Endpoints in Atopic Dermatitis in Children (CREAD-C)--Funded by Regeneron
AAD-PEPR: Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments Sub-Study: Clinically Relevant Endpoints in Atopic Dermatitis in Children (CREAD-C)--Funded by Regeneron
Enrollment Status: Completed
Publish Date: October 09, 2020
Intervention Type: Other
Study Phase: Not Applicable
Pre-SunBeam Pilot Study: Comparative Assessment of TEWL Measurements From AquaFlux vs. Handheld GPSkin Pro in Young Children With and Without AD
Pre-SunBeam Pilot Study: Comparative Assessment of TEWL Measurements From AquaFlux vs. Handheld GPSkin Pro in Young Children With and Without AD
Enrollment Status: Completed
Publish Date: September 07, 2020
Intervention Type: Device
Study Phase: Not Applicable
A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa
A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa
Enrollment Status: Completed
Publish Date: April 09, 2020
Intervention Type: Drug
Study Phase: Phase 3
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
Enrollment Status: Terminated
Publish Date: November 05, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 19 Less Clinical Trials

477 Total Publications

Darier Disease is a Syndromic Epidermal Differentiation Disorder: reply from authors.
Darier Disease is a Syndromic Epidermal Differentiation Disorder: reply from authors.
Journal: The British journal of dermatology
Published: November 14, 2025
View All 477 Publications
Similar Doctors
Distinguished in Mosaicism
Dr. William B. Dobyns
Medical Genetics | Pediatrics | Pediatric Neurology
Distinguished in Mosaicism
Dr. William B. Dobyns
Medical Genetics | Pediatrics | Pediatric Neurology
5841 S Maryland Ave, Mc 0077, 
Chicago, IL 
 (7.4 miles away)
773-834-0525
Languages Spoken:
English
See accepted insurances
Accepting New Patients

William Dobyns is a Medical Genetics specialist and a Pediatrics provider in Chicago, Illinois. Dr. Dobyns is rated as an Elite provider by MediFind in the treatment of Mosaicism. His top areas of expertise are Increased Head Circumference, Cortical Dysplasia, Cerebellar Hypoplasia, and Lissencephaly. Dr. Dobyns is currently accepting new patients.

Distinguished in Mosaicism
Dr. Elizabeth M. Berry-Kravis
Pediatric Neurology | Pediatrics | Psychiatry
Distinguished in Mosaicism
Dr. Elizabeth M. Berry-Kravis
Pediatric Neurology | Pediatrics | Psychiatry

Rush University Medical Group

1725 W Harrison St, 
Chicago, IL 
 (3.3 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Elizabeth Berry-Kravis is a Pediatric Neurologist and a Pediatrics provider in Chicago, Illinois. Dr. Berry-Kravis is rated as an Elite provider by MediFind in the treatment of Mosaicism. Her top areas of expertise are Fragile X Syndrome, Niemann-Pick Disease, Autism Spectrum Disorder, and Rett Syndrome. Dr. Berry-Kravis is currently accepting new patients.

Experienced in Mosaicism
Dr. Gifty Bhat
Medical Genetics | Pediatrics
Experienced in Mosaicism
Dr. Gifty Bhat
Medical Genetics | Pediatrics
1801 W Taylor St Ste 2e, Ui Health Occ, 
Chicago, IL 
 (4.0 miles away)
312-996-7416
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Gifty Bhat is a Medical Genetics specialist and a Pediatrics provider in Chicago, Illinois. Dr. Bhat is rated as a Distinguished provider by MediFind in the treatment of Mosaicism. Her top areas of expertise are Microcephaly, HNRNPH2-Related Disorder, Chromosome 6q Duplication, and Chromosome 8p Deletion. Dr. Bhat is currently accepting new patients.

VIEW MORE MOSAICISM DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Paller's expertise for a condition
ConditionClose
    • Distinguished
    • Clouston Syndrome
      Dr. Paller is
      Distinguished
      . Learn about Clouston Syndrome.
      See more Clouston Syndrome experts
    • Discoid Lupus Erythematosus (DLE)
      Dr. Paller is
      Distinguished
      . Learn about Discoid Lupus Erythematosus (DLE).
      See more Discoid Lupus Erythematosus (DLE) experts
    • Ectodermal Dysplasias
      Dr. Paller is
      Distinguished
      . Learn about Ectodermal Dysplasias.
      See more Ectodermal Dysplasias experts
    • Plaque Psoriasis
      Dr. Paller is
      Distinguished
      . Learn about Plaque Psoriasis.
      See more Plaque Psoriasis experts
    • Advanced
    • AEC Syndrome
      Dr. Paller is
      Advanced
      . Learn about AEC Syndrome.
      See more AEC Syndrome experts
    • Aplasia Cutis Congenita
      Dr. Paller is
      Advanced
      . Learn about Aplasia Cutis Congenita.
      See more Aplasia Cutis Congenita experts
    • EEC Syndrome
      Dr. Paller is
      Advanced
      . Learn about EEC Syndrome.
      See more EEC Syndrome experts
    • Naegeli-Franceschetti-Jadassohn Syndrome
      Dr. Paller is
      Advanced
      . Learn about Naegeli-Franceschetti-Jadassohn Syndrome.
      See more Naegeli-Franceschetti-Jadassohn Syndrome experts
    • Stork Bite
      Dr. Paller is
      Advanced
      . Learn about Stork Bite.
      See more Stork Bite experts
    • Vascular Birthmark
      Dr. Paller is
      Advanced
      . Learn about Vascular Birthmark.
      See more Vascular Birthmark experts
    View All 7 Advanced Conditions
    • Experienced
    • Bjornstad Syndrome
      Dr. Paller is
      Experienced
      . Learn about Bjornstad Syndrome.
      See more Bjornstad Syndrome experts
    • Cardiofaciocutaneous Syndrome
      Dr. Paller is
      Experienced
      . Learn about Cardiofaciocutaneous Syndrome.
      See more Cardiofaciocutaneous Syndrome experts
    • CHARGE Syndrome
      Dr. Paller is
      Experienced
      . Learn about CHARGE Syndrome.
      See more CHARGE Syndrome experts
    • Early Infantile Epileptic Encephalopathy
      Dr. Paller is
      Experienced
      . Learn about Early Infantile Epileptic Encephalopathy.
      See more Early Infantile Epileptic Encephalopathy experts
    • Epilepsy in Children
      Dr. Paller is
      Experienced
      . Learn about Epilepsy in Children.
      See more Epilepsy in Children experts
    • Esophagitis
      Dr. Paller is
      Experienced
      . Learn about Esophagitis.
      See more Esophagitis experts
    View All 23 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.